Experimental Human Pneumococcal Challenge can be performed safely and is associated with low rates of rescue antibiotic use in healthy adults

R. Robinson (Liverpool, United Kingdom), C. Myerscough (Liverpool, United Kingdom), H. Hill (Liverpool, United Kingdom), W. Shephard (Liverpool, United Kingdom), K. Liatsikos (Liverpool, United Kingdom), S. Latham (Liverpool, United Kingdom), F. Fyles (Liverpool, United Kingdom), K. Doherty (Liverpool, United Kingdom), F. Shiham (Liverpool, United Kingdom), D. Mclenghan (Liverpool, United Kingdom), A. Hyder-Wright (Liverpool, United Kingdom), E. Mitsi (Liverpool, United Kingdom), H. Burhan (Liverpool, United Kingdom), B. Morton (Liverpool, United Kingdom), S. Gordon (Blantyre, Malawi), A. Collins (Liverpool, United Kingdom), D. Ferreira (Liverpool, United Kingdom)

Source: International Congress 2022 – Vaccination
Session: Vaccination
Session type: Thematic Poster
Number: 1123

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Robinson (Liverpool, United Kingdom), C. Myerscough (Liverpool, United Kingdom), H. Hill (Liverpool, United Kingdom), W. Shephard (Liverpool, United Kingdom), K. Liatsikos (Liverpool, United Kingdom), S. Latham (Liverpool, United Kingdom), F. Fyles (Liverpool, United Kingdom), K. Doherty (Liverpool, United Kingdom), F. Shiham (Liverpool, United Kingdom), D. Mclenghan (Liverpool, United Kingdom), A. Hyder-Wright (Liverpool, United Kingdom), E. Mitsi (Liverpool, United Kingdom), H. Burhan (Liverpool, United Kingdom), B. Morton (Liverpool, United Kingdom), S. Gordon (Blantyre, Malawi), A. Collins (Liverpool, United Kingdom), D. Ferreira (Liverpool, United Kingdom). Experimental Human Pneumococcal Challenge can be performed safely and is associated with low rates of rescue antibiotic use in healthy adults. 1123

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.